LINK . SPRINGER . COM {}

Matching Content Categories {📚}

• Education
• Science
• Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

The income method remains a mystery to us.

While many websites aim to make money, others are created to share knowledge or showcase creativity. People build websites for various reasons. This could be one of them. Link.springer.com might be plotting its profit, but the way they're doing it isn't detectable yet.

Keywords {🔍}

article, melanoma, pubmed, dendritic, patients, google, scholar, cells, mrna, adjuvant, stage, van, cas, trimixdcmel, study, contributed, draft, financial, analyses, revision, cancer, treatment, oncol, clinical, corthals, iii, autologous, therapy, clin, central, nuffel, amt, patient, statistical, interest, immunotherapy, electroporated, monocytederived, survival, med, wilgenhof, privacy, cookies, content, data, jansen, arm, access, httpsdoiorgjco, cell,

Topics {✒️}

trimixdc-mel-related adverse events pieter-jan van dam long-term clinical outcome pieter-jan van dam4 electroporated dendritic cells advisory role-bristol-myers squibb nonvaccine anti-tumor cells month download article/chapter t-regulatory cells correlate formalin-fixed paraffin-embedded t-cell stimulatory capacity broad t-cell response single-step antigen loading immune-related lncrna pairs circulating dendritic cells human dendritic cells dendritic cells loaded article cancer immunology full article pdf dendritic cell-bank honoraria-bristol-myers squibb van nuffel amt pd-l1 immunohistochemical staining dendritic cells immunotherapy article mrna expression profiling pj van dam stage iii melanoma durable tumor response resected stage iii phase ii study privacy choices/manage cookies bristol-myers squibb constitutively activated tlr4 ipilimumab adjuvant therapy adjuvant trimixdc-mel anti-tumor activity kris thielemans pretreated advanced melanoma institution received honoraria article jansen trimixdc-mel arm tumor tissue samples advanced melanoma patients melanoma patients treated phase ib study attended advisory boards immunotherapy aims post-infusion chills american joint committee

Schema {🗺️}

WebPage:
      mainEntity:
         headline:A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases
         description:Autologous monocyte-derived mRNA co-electroporated dendritic cells with mRNA encoding CD40 ligand (CD40L), CD70 and a constitutively activated TLR4 (caTLR4) (referred to as TriMixDC-MEL) have anti-tumor activity in advanced melanoma patients. We investigated the safety and activity of adjuvant TriMixDC-MEL in stage III/IV melanoma patients. Forty-one patients were randomly assigned to treatment with TriMixDC-MEL (n = 21) and standard follow-up (n = 20). “Cross-over” was allowed at the time of non-salvageable recurrence. The primary endpoint was the percentage of patients alive and disease-free at 1-year. For a subset of patients, (formalin-fixed paraffin-embedded), tumor tissue samples were available for mRNA expression profiling and PD-L1 immunohistochemical staining. Baseline characteristics were well balanced. One-year after randomization, 71% of patients in the study arm were alive and free of disease compared to 35% in the control arm. After a median follow-up of 53 months (range 3–67), 23 patients experienced a non-salvageable melanoma recurrence (TriMixDC-Mel arm n = 9 and control arm n = 14).The median time to non-salvageable recurrence was superior in the TriMixDC-MEL arm (median 8 months (range 1–6) vs. not reached; log-rank p 0.044). TriMixDC-MEL-related adverse events (AE) consisted of transient local skin reactions, flu-like symptoms and post-infusion chills. No grade ≥ 3 AE’s occurred. The mRNA expression profiling revealed four genes (STAT2, TPSAB1, CD9 and CSF2) as potential predictive biomarkers. TriMixDC-MEL id/iv as adjuvant therapy is tolerable and may improve the 1-year disease-free survival rate. Combination of optimized autologous monocyte-derived DC-formulations warrants further investigation in combination with currently approved adjuvant therapy options.
         datePublished:2020-06-26T00:00:00Z
         dateModified:2020-06-26T00:00:00Z
         pageStart:2589
         pageEnd:2598
         sameAs:https://doi.org/10.1007/s00262-020-02618-4
         keywords:
            TriMixDC-MEL
            Melanoma
            Adjuvant therapy
            Dendritic vaccine
            Oncology
            Immunology
            Cancer Research
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-020-02618-4/MediaObjects/262_2020_2618_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-020-02618-4/MediaObjects/262_2020_2618_Fig2_HTML.png
         isPartOf:
            name:Cancer Immunology, Immunotherapy
            issn:
               1432-0851
               0340-7004
            volumeNumber:69
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Berlin Heidelberg
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Yanina Jansen
               url:http://orcid.org/0000-0002-8322-9841
               affiliation:
                     name:Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB)
                     address:
                        name:Department of Medical Oncology, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Brussels, Belgium
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Vibeke Kruse
               affiliation:
                     name:Universitair Ziekenhuis Gent (UZ Gent)
                     address:
                        name:Department of Medical Oncology, Universitair Ziekenhuis Gent (UZ Gent), Ghent, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jurgen Corthals
               affiliation:
                     name:Vrije Universiteit Brussel
                     address:
                        name:Laboratory of Molecular and Cellular Therapy and Dendritic Cell-bank, Vrije Universiteit Brussel, Brussels, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kelly Schats
               affiliation:
                     name:Histogenex NV
                     address:
                        name:Histogenex NV, Antwerp, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Pieter-Jan van Dam
               affiliation:
                     name:Histogenex NV
                     address:
                        name:Histogenex NV, Antwerp, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Teofila Seremet
               affiliation:
                     name:Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB)
                     address:
                        name:Department of Medical Oncology, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Brussels, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Carlo Heirman
               affiliation:
                     name:Vrije Universiteit Brussel
                     address:
                        name:Laboratory of Molecular and Cellular Therapy and Dendritic Cell-bank, Vrije Universiteit Brussel, Brussels, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Lieve Brochez
               affiliation:
                     name:Universitair Ziekenhuis Gent (UZ Gent)
                     address:
                        name:Department of Medical Oncology, Universitair Ziekenhuis Gent (UZ Gent), Ghent, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mark Kockx
               affiliation:
                     name:Histogenex NV
                     address:
                        name:Histogenex NV, Antwerp, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kris Thielemans
               affiliation:
                     name:Vrije Universiteit Brussel
                     address:
                        name:Laboratory of Molecular and Cellular Therapy and Dendritic Cell-bank, Vrije Universiteit Brussel, Brussels, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Bart Neyns
               affiliation:
                     name:Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB)
                     address:
                        name:Department of Medical Oncology, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Brussels, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases
      description:Autologous monocyte-derived mRNA co-electroporated dendritic cells with mRNA encoding CD40 ligand (CD40L), CD70 and a constitutively activated TLR4 (caTLR4) (referred to as TriMixDC-MEL) have anti-tumor activity in advanced melanoma patients. We investigated the safety and activity of adjuvant TriMixDC-MEL in stage III/IV melanoma patients. Forty-one patients were randomly assigned to treatment with TriMixDC-MEL (n = 21) and standard follow-up (n = 20). “Cross-over” was allowed at the time of non-salvageable recurrence. The primary endpoint was the percentage of patients alive and disease-free at 1-year. For a subset of patients, (formalin-fixed paraffin-embedded), tumor tissue samples were available for mRNA expression profiling and PD-L1 immunohistochemical staining. Baseline characteristics were well balanced. One-year after randomization, 71% of patients in the study arm were alive and free of disease compared to 35% in the control arm. After a median follow-up of 53 months (range 3–67), 23 patients experienced a non-salvageable melanoma recurrence (TriMixDC-Mel arm n = 9 and control arm n = 14).The median time to non-salvageable recurrence was superior in the TriMixDC-MEL arm (median 8 months (range 1–6) vs. not reached; log-rank p 0.044). TriMixDC-MEL-related adverse events (AE) consisted of transient local skin reactions, flu-like symptoms and post-infusion chills. No grade ≥ 3 AE’s occurred. The mRNA expression profiling revealed four genes (STAT2, TPSAB1, CD9 and CSF2) as potential predictive biomarkers. TriMixDC-MEL id/iv as adjuvant therapy is tolerable and may improve the 1-year disease-free survival rate. Combination of optimized autologous monocyte-derived DC-formulations warrants further investigation in combination with currently approved adjuvant therapy options.
      datePublished:2020-06-26T00:00:00Z
      dateModified:2020-06-26T00:00:00Z
      pageStart:2589
      pageEnd:2598
      sameAs:https://doi.org/10.1007/s00262-020-02618-4
      keywords:
         TriMixDC-MEL
         Melanoma
         Adjuvant therapy
         Dendritic vaccine
         Oncology
         Immunology
         Cancer Research
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-020-02618-4/MediaObjects/262_2020_2618_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-020-02618-4/MediaObjects/262_2020_2618_Fig2_HTML.png
      isPartOf:
         name:Cancer Immunology, Immunotherapy
         issn:
            1432-0851
            0340-7004
         volumeNumber:69
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Berlin Heidelberg
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Yanina Jansen
            url:http://orcid.org/0000-0002-8322-9841
            affiliation:
                  name:Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB)
                  address:
                     name:Department of Medical Oncology, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Brussels, Belgium
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Vibeke Kruse
            affiliation:
                  name:Universitair Ziekenhuis Gent (UZ Gent)
                  address:
                     name:Department of Medical Oncology, Universitair Ziekenhuis Gent (UZ Gent), Ghent, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jurgen Corthals
            affiliation:
                  name:Vrije Universiteit Brussel
                  address:
                     name:Laboratory of Molecular and Cellular Therapy and Dendritic Cell-bank, Vrije Universiteit Brussel, Brussels, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kelly Schats
            affiliation:
                  name:Histogenex NV
                  address:
                     name:Histogenex NV, Antwerp, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Pieter-Jan van Dam
            affiliation:
                  name:Histogenex NV
                  address:
                     name:Histogenex NV, Antwerp, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Teofila Seremet
            affiliation:
                  name:Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB)
                  address:
                     name:Department of Medical Oncology, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Brussels, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Carlo Heirman
            affiliation:
                  name:Vrije Universiteit Brussel
                  address:
                     name:Laboratory of Molecular and Cellular Therapy and Dendritic Cell-bank, Vrije Universiteit Brussel, Brussels, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Lieve Brochez
            affiliation:
                  name:Universitair Ziekenhuis Gent (UZ Gent)
                  address:
                     name:Department of Medical Oncology, Universitair Ziekenhuis Gent (UZ Gent), Ghent, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mark Kockx
            affiliation:
                  name:Histogenex NV
                  address:
                     name:Histogenex NV, Antwerp, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kris Thielemans
            affiliation:
                  name:Vrije Universiteit Brussel
                  address:
                     name:Laboratory of Molecular and Cellular Therapy and Dendritic Cell-bank, Vrije Universiteit Brussel, Brussels, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Bart Neyns
            affiliation:
                  name:Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB)
                  address:
                     name:Department of Medical Oncology, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Brussels, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cancer Immunology, Immunotherapy
      issn:
         1432-0851
         0340-7004
      volumeNumber:69
Organization:
      name:Springer Berlin Heidelberg
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB)
      address:
         name:Department of Medical Oncology, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Brussels, Belgium
         type:PostalAddress
      name:Universitair Ziekenhuis Gent (UZ Gent)
      address:
         name:Department of Medical Oncology, Universitair Ziekenhuis Gent (UZ Gent), Ghent, Belgium
         type:PostalAddress
      name:Vrije Universiteit Brussel
      address:
         name:Laboratory of Molecular and Cellular Therapy and Dendritic Cell-bank, Vrije Universiteit Brussel, Brussels, Belgium
         type:PostalAddress
      name:Histogenex NV
      address:
         name:Histogenex NV, Antwerp, Belgium
         type:PostalAddress
      name:Histogenex NV
      address:
         name:Histogenex NV, Antwerp, Belgium
         type:PostalAddress
      name:Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB)
      address:
         name:Department of Medical Oncology, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Brussels, Belgium
         type:PostalAddress
      name:Vrije Universiteit Brussel
      address:
         name:Laboratory of Molecular and Cellular Therapy and Dendritic Cell-bank, Vrije Universiteit Brussel, Brussels, Belgium
         type:PostalAddress
      name:Universitair Ziekenhuis Gent (UZ Gent)
      address:
         name:Department of Medical Oncology, Universitair Ziekenhuis Gent (UZ Gent), Ghent, Belgium
         type:PostalAddress
      name:Histogenex NV
      address:
         name:Histogenex NV, Antwerp, Belgium
         type:PostalAddress
      name:Vrije Universiteit Brussel
      address:
         name:Laboratory of Molecular and Cellular Therapy and Dendritic Cell-bank, Vrije Universiteit Brussel, Brussels, Belgium
         type:PostalAddress
      name:Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB)
      address:
         name:Department of Medical Oncology, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Brussels, Belgium
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Yanina Jansen
      url:http://orcid.org/0000-0002-8322-9841
      affiliation:
            name:Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB)
            address:
               name:Department of Medical Oncology, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Brussels, Belgium
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Vibeke Kruse
      affiliation:
            name:Universitair Ziekenhuis Gent (UZ Gent)
            address:
               name:Department of Medical Oncology, Universitair Ziekenhuis Gent (UZ Gent), Ghent, Belgium
               type:PostalAddress
            type:Organization
      name:Jurgen Corthals
      affiliation:
            name:Vrije Universiteit Brussel
            address:
               name:Laboratory of Molecular and Cellular Therapy and Dendritic Cell-bank, Vrije Universiteit Brussel, Brussels, Belgium
               type:PostalAddress
            type:Organization
      name:Kelly Schats
      affiliation:
            name:Histogenex NV
            address:
               name:Histogenex NV, Antwerp, Belgium
               type:PostalAddress
            type:Organization
      name:Pieter-Jan van Dam
      affiliation:
            name:Histogenex NV
            address:
               name:Histogenex NV, Antwerp, Belgium
               type:PostalAddress
            type:Organization
      name:Teofila Seremet
      affiliation:
            name:Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB)
            address:
               name:Department of Medical Oncology, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Brussels, Belgium
               type:PostalAddress
            type:Organization
      name:Carlo Heirman
      affiliation:
            name:Vrije Universiteit Brussel
            address:
               name:Laboratory of Molecular and Cellular Therapy and Dendritic Cell-bank, Vrije Universiteit Brussel, Brussels, Belgium
               type:PostalAddress
            type:Organization
      name:Lieve Brochez
      affiliation:
            name:Universitair Ziekenhuis Gent (UZ Gent)
            address:
               name:Department of Medical Oncology, Universitair Ziekenhuis Gent (UZ Gent), Ghent, Belgium
               type:PostalAddress
            type:Organization
      name:Mark Kockx
      affiliation:
            name:Histogenex NV
            address:
               name:Histogenex NV, Antwerp, Belgium
               type:PostalAddress
            type:Organization
      name:Kris Thielemans
      affiliation:
            name:Vrije Universiteit Brussel
            address:
               name:Laboratory of Molecular and Cellular Therapy and Dendritic Cell-bank, Vrije Universiteit Brussel, Brussels, Belgium
               type:PostalAddress
            type:Organization
      name:Bart Neyns
      affiliation:
            name:Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB)
            address:
               name:Department of Medical Oncology, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Brussels, Belgium
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Medical Oncology, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Brussels, Belgium
      name:Department of Medical Oncology, Universitair Ziekenhuis Gent (UZ Gent), Ghent, Belgium
      name:Laboratory of Molecular and Cellular Therapy and Dendritic Cell-bank, Vrije Universiteit Brussel, Brussels, Belgium
      name:Histogenex NV, Antwerp, Belgium
      name:Histogenex NV, Antwerp, Belgium
      name:Department of Medical Oncology, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Brussels, Belgium
      name:Laboratory of Molecular and Cellular Therapy and Dendritic Cell-bank, Vrije Universiteit Brussel, Brussels, Belgium
      name:Department of Medical Oncology, Universitair Ziekenhuis Gent (UZ Gent), Ghent, Belgium
      name:Histogenex NV, Antwerp, Belgium
      name:Laboratory of Molecular and Cellular Therapy and Dendritic Cell-bank, Vrije Universiteit Brussel, Brussels, Belgium
      name:Department of Medical Oncology, Universitair Ziekenhuis Brussel (UZ Brussel), Vrije Universiteit Brussel (VUB), Brussels, Belgium
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(138)

• Get to know https://www.springernature.com/gp/authors's earnings
• Explore the financials of https://link.springernature.com/home/
• What's the income of https://order.springer.com/public/cart?
• How much does https://submission.nature.com/new-submission/262/3 net monthly?
• How much income does https://orcid.org/0000-0002-8322-9841 have?
• What's the revenue for https://www.springernature.com/gp/librarians/licensing/agc/journals?
• How much does https://doi.org/10.1172/JCI91190 pull in?
• How much profit is https://doi.org/10.1172%2FJCI91190 making per month?
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28650338 generate?
• Profit of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531419
• What's the profit of http://scholar.google.com/scholar_lookup?&title=IFN-%CE%B3%E2%80%93related%20mRNA%20profile%20predicts%20clinical%20response%20to%20PD-1%20blockade&journal=J%20Clin%20Invest&doi=10.1172%2FJCI91190&volume=127&issue=8&pages=2930-2940&publication_year=2017&author=Ayers%2CM&author=Lunceford%2CJ&author=Nebozhyn%2CM&author=Murphy%2CE&author=Loboda%2CA&author=Kaufman%2CDR?
• What is the earnings of https://doi.org/10.1200/JCO.2009.27.1627?
• What's the financial outcome of https://doi.org/10.1200%2FJCO.2009.27.1627?
• How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20368546 earning monthly?
• How much profit does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2982783 make?
• Revenue of http://scholar.google.com/scholar_lookup?&title=Multivariate%20analysis%20of%20prognostic%20factors%20among%202%2C313%20patients%20with%20stage%20III%20melanoma%3A%20comparison%20of%20nodal%20micrometastases%20versus%20macrometastases&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2009.27.1627&volume=28&pages=2452-2459&publication_year=2010&author=Balch%2CCM&author=Gershenwald%2CJE&author=Soong%2CS
• Income figures for https://doi.org/10.1080/2162402X.2015.1057673
• How much does https://doi.org/10.1080%2F2162402X.2015.1057673 pull in monthly?
• How much cash flow does http://scholar.google.com/scholar_lookup?&title=Favorable%20overall%20survival%20in%20stage%20III%20melanoma%20patients%20after%20adjuvant%20dendritic%20cell%20vaccination&journal=Oncoimmunology&doi=10.1080%2F2162402X.2015.1057673&volume=5&pages=1-8&publication_year=2016&author=Bol%2CKF&author=Aarntzen%2CEHJG&author=in%E2%80%99t%20Hout%2CFEM have monthly?
• What's the income generated by https://doi.org/10.1038/mt.2008.77 each month?
• Learn about the earnings of https://doi.org/10.1038%2Fmt.2008.77
• Revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18431362
• What's the income generated by http://scholar.google.com/scholar_lookup?&title=Enhancing%20the%20T-cell%20stimulatory%20capacity%20of%20human%20dendritic%20cells%20by%20co-electroporation%20with%20CD40L%2C%20CD70%20and%20constitutively%20active%20TLR4%20encoding%20mRNA&journal=Mol%20Ther&doi=10.1038%2Fmt.2008.77&volume=16&pages=1170-1180&publication_year=2008&author=Bonehill%2CA&author=Tuyaerts%2CS&author=Nuffel%2CAMT each month?
• Explore the financials of https://doi.org/10.1158/1078-0432.CCR-08-2982
• https://doi.org/10.1158%2F1078-0432.CCR-08-2982's financial summary
• What's http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19417017's gross income?
• Financial intake of http://scholar.google.com/scholar_lookup?&title=Single-step%20antigen%20loading%20and%20activation%20of%20dendritic%20cells%20by%20mRNA%20electroporation%20for%20the%20purpose%20of%20therapeutic%20vaccination%20in%20melanoma%20patients&journal=Clin%20Cancer%20Res&doi=10.1158%2F1078-0432.CCR-08-2982&volume=15&pages=3366-3375&publication_year=2009&author=Bonehill%2CA&author=Nuffel%2CAMT&author=Corthals%2CJ
• Monthly income for https://doi.org/10.1200/jco.2009.23.4799
• Earnings of https://doi.org/10.1200%2Fjco.2009.23.4799
• http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=19917835 income
• What's the profit of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2793035?
• How much does http://scholar.google.com/scholar_lookup?&title=Final%20version%20of%202009%20AJCC%20melanoma%20staging%20and%20classification&journal=J%20Clin%20Oncol&doi=10.1200%2Fjco.2009.23.4799&volume=27&pages=6199-6206&publication_year=2009&author=Byrd%2CDR&author=Sondak%2CVK&author=Soong%2CS pull in?
• What's the monthly income of https://doi.org/10.4049/jimmunol.180.5.3585?
• What is the earnings of https://doi.org/10.4049%2Fjimmunol.180.5.3585?
• How much income does http://scholar.google.com/scholar_lookup?&title=Vaccination%20of%20a%20melanoma%20patient%20with%20mature%20dendritic%20cells%20pulsed%20with%20MAGE-3%20peptides%20triggers%20the%20activity%20of%20nonvaccine%20anti-tumor%20cells&journal=J%20Immunol&doi=10.4049%2Fjimmunol.180.5.3585&volume=180&pages=3585-3593&publication_year=2014&author=Carrasco%2CJ&author=Pel%2CA&author=Neyns%2CB have?
• How much revenue does https://doi.org/10.1200/JCO.2016.67.2477 bring in?
• How much cash flow does https://doi.org/10.1200%2FJCO.2016.67.2477 have monthly?
• How much income is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27863197 earning monthly?
• Get to know what's the income of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562434
• What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Programmed%20death-ligand%201%20expression%20and%20response%20to%20the%20anti-programmed%20death%201%20antibody%20pembrolizumab%20in%20melanoma&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2016.67.2477&volume=34&pages=4102-4109&publication_year=2016&author=Daud%2CAI&author=Wolchok%2CJD&author=Robert%2CC?
• What is the monthly revenue of https://doi.org/10.1056/NEJMoa1802357?
• How much revenue does https://doi.org/10.1056%2FNEJMoa1802357 produce monthly?
• Check the income stats for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=29658430
• Explore the financials of http://scholar.google.com/scholar_lookup?&title=Adjuvant%20pembrolizumab%20versus%20placebo%20in%20resected%20stage%20III%20melanoma&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1802357&volume=378&pages=1789-1801&publication_year=2018&author=Eggermont%2CAMM&author=Blank%2CCU&author=Mandala%2CM
• What's the income of https://doi.org/10.1056/NEJMoa1611299?
• What's the financial gain of https://doi.org/10.1056%2FNEJMoa1611299?
• What's the financial outcome of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=27717298?
• How much does http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648545 pull in monthly?
• How much money does http://scholar.google.com/scholar_lookup?&title=Prolonged%20survival%20in%20stage%20III%20melanoma%20with%20ipilimumab%20adjuvant%20therapy&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1611299&volume=375&pages=1845-1855&publication_year=2016&author=Eggermont%2CAMM&author=Chiarion-Sileni%2CV&author=Grob%2CJ-J make?
• What's the revenue for https://doi.org/10.1056/nejmoa1708539?
• What is the monthly revenue of https://doi.org/10.1056%2Fnejmoa1708539?
• How much does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28891408 rake in every month?
• Income figures for http://scholar.google.com/scholar_lookup?&title=Adjuvant%20dabrafenib%20plus%20trametinib%20in%20stage%20III%20BRAF-mutated%20melanoma&journal=N%20Engl%20J%20Med&doi=10.1056%2Fnejmoa1708539&volume=377&pages=1813-1823&publication_year=2017&author=Long%2CGV&author=Hauschild%2CA&author=Santinami%2CM
• What's the total monthly financial gain of https://doi.org/10.1007/s12032-012-0168-1?
• Monthly income for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22302285
• Financial intake of http://scholar.google.com/scholar_lookup?&title=Adjuvant%20vaccination%20with%20melanoma%20antigen-pulsed%20dendritic%20cells%20in%20stage%20III%20melanoma%20patients&journal=Med%20Oncol&doi=10.1007%2Fs12032-012-0168-1&volume=29&pages=2966-2977&publication_year=2012&author=Markowicz%2CS&author=Nowecki%2CZI&author=Rutkowski%2CP
• What are the total earnings of https://doi.org/10.1002/14651858.cd008955.pub2?
• How much profit does https://doi.org/10.1002%2F14651858.cd008955.pub2 generate?
• See how much http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=23775773 makes per month
• Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Interferon%20alpha%20for%20the%20adjuvant%20treatment%20of%20cutaneous%20melanoma&journal=Cochrane%20Database%20Syst%20Rev&doi=10.1002%2F14651858.cd008955.pub2&publication_year=2013&author=Mocellin%2CS&author=Lens%2CMB&author=Pasquali%2CS
• Get to know https://doi.org/10.1016/S1470-2045(06)70938-X's earnings
• Find out how much https://doi.org/10.1016%2FS1470-2045%2806%2970938-X earns monthly
• How profitable is http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=17081917?
• How much does http://scholar.google.com/scholar_lookup?&title=Complete%20metastasectomy%20in%20patients%20with%20stage%20IV%20metastatic%20melanoma&journal=Lancet%20Oncol&doi=10.1016%2FS1470-2045%2806%2970938-X&volume=7&pages=919-924&publication_year=2006&author=Ollila%2CDW generate monthly?
• Income figures for https://doi.org/10.1200/JCO.2009.26.2063
• How much does https://doi.org/10.1200%2FJCO.2009.26.2063 pull in?
• Explore the financials of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=20479405
• http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3664035 income
• Income figures for http://scholar.google.com/scholar_lookup?&title=Site%20and%20timing%20of%20first%20relapse%20in%20stage%20III%20melanoma%20patients%3A%20implications%20for%20follow-up%20guidelines&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2009.26.2063&volume=28&pages=3042-3047&publication_year=2010&author=Romano%2CE&author=Scordo%2CM&author=Dusza%2CSW
• How much does https://doi.org/10.1038/mt.2012.11 gross monthly?
• How much cash flow does https://doi.org/10.1038%2Fmt.2012.11 have monthly?
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22371843 generate?
• What are the earnings of http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3345975?
• What's the revenue for http://scholar.google.com/scholar_lookup?&title=Dendritic%20cells%20loaded%20with%20mRNA%20encoding%20full-length%20tumor%20antigens%20prime%20CD4%E2%80%89%2B%E2%80%89and%20CD8%E2%80%89%2B%E2%80%89T%20cells%20in%20melanoma%20patients&journal=Mol%20Ther&doi=10.1038%2Fmt.2012.11&volume=20&pages=1063-1074&publication_year=2012&author=Nuffel%2CAMT&author=Benteyn%2CD&author=Wilgenhof%2CS?
• How much income does https://doi.org/10.1007/s00262-011-1176-2 have?
• Income figures for http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=22159452
• How much cash flow does http://scholar.google.com/scholar_lookup?&title=Intravenous%20and%20intradermal%20TriMix-dendritic%20cell%20therapy%20results%20in%20a%20broad%20T-cell%20response%20and%20durable%20tumor%20response%20in%20a%20chemorefractory%20stage%20IV-M1c%20melanoma%20patient&journal=Cancer%20Immunol%20Immunother&doi=10.1007%2Fs00262-011-1176-2&volume=61&pages=1033-1043&publication_year=2012&author=Nuffel%2CAMT&author=Benteyn%2CD&author=Wilgenhof%2CS have monthly?
• How much money does https://doi.org/10.1056/NEJMoa1709030 make?
• See how much https://doi.org/10.1056%2FNEJMoa1709030 makes per month
• How much income does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=28891423 have?
• How much does http://scholar.google.com/scholar_lookup?&title=Adjuvant%20nivolumab%20versus%20ipilimumab%20in%20resected%20stage%20III%20or%20IV%20melanoma&journal=N%20Engl%20J%20Med&doi=10.1056%2FNEJMoa1709030&volume=377&pages=1824-1835&publication_year=2017&author=Weber%2CJ&author=Mandala%2CM&author=Vecchio%2CM bring in each month?
• What is the earnings of https://doi.org/10.1200/JCO.2015.63.4121?
• How much profit does https://doi.org/10.1200%2FJCO.2015.63.4121 generate?
• What is the earnings of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=26926680?
• What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Phase%20II%20study%20of%20autologous%20monocyte-derived%20mRNA%20electroporated%20dendritic%20cells%20%28TriMixDC-MEL%29%20plus%20ipilimumab%20in%20patients%20with%20pretreated%20advanced%20melanoma&journal=J%20Clin%20Oncol&doi=10.1200%2FJCO.2015.63.4121&volume=34&pages=1330-1338&publication_year=2016&author=Wilgenhof%2CS&author=Corthals%2CJ&author=Heirman%2CC?
• See how much https://doi.org/10.1007/s00262-014-1642-8 makes per month
• How much profit does http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=25548092 generate?
• What's the monthly income of http://scholar.google.com/scholar_lookup?&title=Long-term%20clinical%20outcome%20of%20melanoma%20patients%20treated%20with%20messenger%20RNA-electroporated%20dendritic%20cell%20therapy%20following%20complete%20resection%20of%20metastases&journal=Cancer%20Immunol%20Immunother&doi=10.1007%2Fs00262-014-1642-8&volume=64&pages=381-388&publication_year=2015&author=Wilgenhof%2CS&author=Corthals%2CJ&author=Nuffel%2CAMT?
• How much money does https://doi.org/10.1093/annonc/mdt245 generate?
• How much revenue does https://doi.org/10.1093%2Fannonc%2Fmdt245 generate?
• Get to know http://scholar.google.com/scholar_lookup?&title=A%20phase%20IB%20study%20on%20intravenous%20synthetic%20mRNA%20electroporated%20dendritic%20cell%20immunotherapy%20in%20pretreated%20advanced%20melanoma%20patients&journal=Ann%20Oncol%20Off%20J%20Eur%20Soc%20Med%20Oncol&doi=10.1093%2Fannonc%2Fmdt245&volume=24&pages=2686-2693&publication_year=2013&author=Wilgenhof%2CS&author=Nuffel%2CAMT&author=Benteyn%2CD's earnings
• What is the earnings of https://doi.org/10.1097/CJI.0b013e31821dcb31?
• https://doi.org/10.1097%2FCJI.0b013e31821dcb31 income
• What is the monthly revenue of http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=21577140?
• How much money does http://scholar.google.com/scholar_lookup?&title=Therapeutic%20vaccination%20with%20an%20autologous%20mRNA%20electroporated%20dendritic%20cell%20vaccine%20in%20patients%20with%20advanced%20melanoma&journal=J%20Immunother&doi=10.1097%2FCJI.0b013e31821dcb31&volume=34&pages=448-456&publication_year=2011&author=Wilgenhof%2CS&author=Nuffel%2CAMT&author=Corthals%2CJ make?
• What's the income generated by https://citation-needed.springer.com/v2/references/10.1007/s00262-020-02618-4?format=refman&flavour=references each month?
• What's the monthly income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Yanina%20Jansen?
• How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Yanina%20Jansen%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en bring in each month?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Vibeke%20Kruse earn?
• How much cash flow does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Vibeke%20Kruse%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have monthly?
• What's the monthly income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Jurgen%20Corthals?
• What is the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Jurgen%20Corthals%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much profit does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kelly%20Schats make?
• Revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kelly%20Schats%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• What's the monthly income of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Pieter-Jan%20van%20Dam?
• What's the total monthly financial gain of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Pieter-Jan%20van%20Dam%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Teofila%20Seremet pull in?
• Income figures for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Teofila%20Seremet%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• Learn about the earnings of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Carlo%20Heirman
• Monthly income for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Carlo%20Heirman%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
• What's the profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Lieve%20Brochez?
• What's the revenue for https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Lieve%20Brochez%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• Financial intake of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Mark%20Kockx
• How much profit is https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Mark%20Kockx%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en making per month?
• How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Kris%20Thielemans make?
• What's the profit of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Kris%20Thielemans%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
• How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Bart%20Neyns generate?
• How much income does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Bart%20Neyns%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en have?
• What's the monthly income of https://static-content.springer.com/esm/art%3A10.1007%2Fs00262-020-02618-4/MediaObjects/262_2020_2618_MOESM1_ESM.docx?
• https://s100.copyright.com/AppDispatchServlet?title=A%20randomized%20controlled%20phase%20II%20clinical%20trial%20on%20mRNA%20electroporated%20autologous%20monocyte-derived%20dendritic%20cells%20%28TriMixDC-MEL%29%20as%20adjuvant%20treatment%20for%20stage%20III%2FIV%20melanoma%20patients%20who%20are%20disease-free%20following%20the%20resection%20of%20macrometastases&author=Yanina%20Jansen%20et%20al&contentID=10.1007%2Fs00262-020-02618-4©right=Springer-Verlag%20GmbH%20Germany%2C%20part%20of%20Springer%20Nature&publication=0340-7004&publicationDate=2020-06-26&publisherName=SpringerNature&orderBeanReset=true income
• What's the total monthly financial gain of https://crossmark.crossref.org/dialog/?doi=10.1007/s00262-020-02618-4?
• How much does https://citation-needed.springer.com/v2/references/10.1007/s00262-020-02618-4?format=refman&flavour=citation make?
• How much revenue does https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral produce monthly?
• What's the income generated by https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research each month?
• What's the financial gain of https://www.springernature.com/gp/products?
• How much does https://www.springernature.com/gp/librarians gross monthly?
• What's the revenue for https://www.springernature.com/gp/societies?
• Earnings of https://www.springernature.com/gp/partners
• What's the income generated by https://www.springer.com/ each month?
• What's the financial outcome of https://www.nature.com/?
• What's the monthly money flow for https://www.biomedcentral.com/?
• https://www.palgrave.com/ income
• What's the revenue for https://www.apress.com/?
• What are the earnings of https://www.springernature.com/gp/legal/ccpa?
• What's https://www.springernature.com/gp/info/accessibility's gross income?
• What's the monthly money flow for https://support.springernature.com/en/support/home?
• Get to know https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations's earnings
• Income figures for https://www.springernature.com/

Analytics and Tracking {📊}

• Google Tag Manager

Libraries {📚}

• Clipboard.js
• Prism.js